This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Bioprocessing & Manufacturing

REPORT: COVID-19 One Year On - Impacts on the Global Life Sciences Industry 2021

Posted by on 11 August 2021
Share this article

In April 2020, with the true extent of COVID-19 impacts only just fully emerging and lockdowns just being put in place in many parts of the world, Informa Connect Life Sciences asked the global life sciences community about the impacts the pandemic was having on the industry and their response to it. We got a huge response with over 600 industry professionals completing the survey, which provided the data for a fascinating report.

A year on, we wanted to see how the picture has changed, so conducted a follow up study of life sciences professionals from the pharma, biotech, medical device and regulatory industries around the world. The survey was completed 379 times and the data - presented in this report - reveals insights into how the global life sciences community has responded to the crisis, the impacts it has had on the different industries, and how the future looks.

Explore the report by clicking on it above or here.

Key Insights

  • 49% of respondents' organizations are working on the development of diagnostics, vaccination or treatment of COVID-19 in some way.
  • 65% think that the COVID-19 vaccine response will have a long term impact on accelerated regulatory approval.
  • 87% of respondents' supply chains are still being impacted by the pandemic.
  • 48% currently have reduced pipelines due to the pandemic. 
  • 59% are working at home full time, compared to 68% in 2020

Explore the report by clicking on it above or here.

Share this article